AI assistant
Jazz Pharmaceuticals plc — Director's Dealing 2016
Aug 16, 2016
30751_dirs_2016-08-15_b9ac3bf0-6b31-4952-8a18-8a980601f5c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-08-11
Reporting Person: Winningham Rick E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-11 | Ordinary Shares | A | 1365.0 | $0.0 | Acquired | 16024 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-11 | Non-Qualified Stock Option (right to buy) | $138.08 | A | 3415.0 | Acquired | 2026-08-10 | Ordinary Shares (3415) | Direct |
Footnotes
F1: These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 4, 2017.
F2: This option is granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vests in 12 equal monthly installments beginning on September 1, 2016.